Saturday, 17 October 2026European Markets

MOREFIELD GROUP Stock Was 9.4% Up Today

Loading stream...

(VIANEWS) - The Market ended the session with MOREFIELD GROUP (MORE.AS) jumping 9.4% to €0.33 on Wednesday, following the last session's downward trend. AEX-Index fell 0.56% to €775.46, following the last session's upward trend on what was a somewhat down trend trading session today.

MOREFIELD GROUP's last close was €0.30, 22.6% under its 52-week high of €0.39.

About MOREFIELD GROUP

Morefield Group N.V. does not have significant operations. Previously, the company was involved in the external professionals hiring activities. The company was formerly known as HeadFirst Source Group N.V. and changed its name to Morefield Group N.V. in January 2019. Morefield Group N.V. is based in Willemstad, Curaçao.

Earnings Per Share

As for profitability, MOREFIELD GROUP has a trailing twelve months EPS of €0.09.

PE Ratio

MOREFIELD GROUP has a trailing twelve months price to earnings ratio of 3.62. Meaning, the purchaser of the share is investing €3.62 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.06%.

Moving Average

MOREFIELD GROUP's value is way higher than its 50-day moving average of €0.29 and higher than its 200-day moving average of €0.30.

More news about MOREFIELD GROUP (MORE.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com